Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NSAIDs. Are there any differences?

B Kaplan1, R A Swain

  • 1Department of Clinical Pharmacy, School of Pharmacy, West Virginia University, Charleston.

Archives of Family Medicine
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mueller matrix of dense polystyrene latex sphere suspensions: measurements and Monte Carlo simulation.

Applied optics·2008
Same author

Use of low dose tacrolimus, mycophenolate mofetil and maintenance IL-2 receptor blockade in an islet transplant recipient.

Clinical transplantation·2008
Same author

Phase-modulated mueller ellipsometry characterization of scattering by latex sphere suspensions.

Applied optics·2008
Same author

Comparison of visual function and ocular hemodynamics between pre- and post-menopausal women.

European journal of ophthalmology·2008
Same author

Prophylaxis versus preemptive protocols for CMV: do they impact graft survival?

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
Same author

Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?

Journal of the European Academy of Dermatology and Venereology : JEADV·2008
Same journal

Living in medicine: med school after 50 years plus 2 weeks

Archives of family medicine·2000
Same journal

Phytophotodermatitis: a sometimes difficult diagnosis.

Archives of family medicine·2000
Same journal

Case description of ascariasis.

Archives of family medicine·2000
Same journal

Microscopic polyangiitis in a pediatric patient.

Archives of family medicine·2000
Same journal

Advance care planning.

Archives of family medicine·2000
Same journal

Gaps in end-of-life care.

Archives of family medicine·2000
See all related articles

Selecting the right nonsteroidal anti-inflammatory drug (NSAID) requires balancing benefits against risks. This guide offers a rational approach for primary care physicians to choose the most appropriate NSAID for individual patients.

Area of Science:

  • Pharmacology
  • Internal Medicine

Background:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently prescribed in the US.
  • NSAID selection often deviates from evidence-based guidelines, despite numerous available agents.
  • Optimal NSAID choice depends on efficacy, safety, cost, and patient-specific factors.

Purpose of the Study:

  • To provide a rational framework for prescribing NSAIDs in primary care.
  • To guide clinicians in selecting NSAIDs based on comprehensive patient profiles.
  • To address the complexity of NSAID choice due to diverse agents and prescribing variations.

Main Methods:

  • Review of current literature on NSAID pharmacology and clinical use.
  • Analysis of factors influencing NSAID selection in primary care.

Related Experiment Videos

  • Development of a decision-making model for NSAID prescribing.

    • Main Results:

    • No single NSAID is universally superior across all selection criteria.
    • Individual patient profiles significantly impact the risk-benefit assessment of NSAIDs.
    • A structured approach can optimize NSAID selection and minimize adverse events.

    Conclusions:

    • A rational, evidence-based approach is crucial for effective NSAID prescribing.
    • Primary care physicians need tools to navigate NSAID complexity.
    • Tailoring NSAID choice to patient needs improves therapeutic outcomes.